Vol. 1, Issue 6 (2013)
Bioprospecting of Moringa (Moringaceae): Microbiological Perspective
Author(s): Daljit Singh Arora*, Jemimah Gesare Onsare and Harpreet Kaur
Abstract: Plants produce primary and secondary metabolites which encompass a wide array of functions. Some of these have been subsequently exploited by humans for their beneficial role in a diverse array of applications. However, out of 750,000 species available on earth, only 1 to 10 % is being potentially used. Moringa is one such genus belonging to the family of Moringaceae, a monotypic family of single genera with around 33 species. Most of these species have not been explored fully despite the enormous bioactivity reports concerning various potentials such as: cardiac and circulatory stimulants; anti-tumor; antipyretic; antiepileptic; anti-inflammatory; antiulcer; antispasmodic; diuretic antihypertensive; cholesterol lowering; antioxidant; antidiabetic; hepato protective; antibacterial and antifungal activities. They are claimed to treat different ailments in the indigenous system of medicine. Surprisingly, some of the species have been reported to be extinct from the face of earth before their exploration and exploitation for economic benefits. This review focuses on the bio-prospects of Moringa particularly on relatively little explored area of their microbiological applications.
How to cite this article:
Daljit Singh Arora*, Jemimah Gesare Onsare, Harpreet Kaur. Bioprospecting of Moringa (Moringaceae): Microbiological Perspective. J Pharmacogn Phytochem 2013;1(6):193-215.